1.Status and Development of Upper Limb Rehabilitation Training System Based on Virtual Reality Technology (review)
Chinese Journal of Rehabilitation Theory and Practice 2014;(10):908-910
The paper overviewed the research progress of the upper limb rehabilitation training system based on virtual reality technology,introduced some kinds of rehabilitation system, especially the software design, and the application of virtual scene, virtual object and network remote in the upper limb rehabilitation, and summarized the problem of applications of virtual reality in the rehabilitation and put forward the prospects about it.
2.Develepment of Hand Function Rehabilitation Evaluation and Training System Based on Virtual Reality Technol-ogy
Yang XIAO ; Xiulin XU ; Yi ZHAI ; Meijun AN
Chinese Journal of Rehabilitation Theory and Practice 2016;22(3):341-344
Objective To develop a system for hand function evaluation and training based on virtual reality. Methods 5DT Data Glove 5 Ultra, Visual Studio 2010 were integrated as the development environment and DirectX 9.0 as components, and the system was developed based on the MFC programming framework. Results and Conclusion The system can assess the fingers function, recognise gestures and can be used as a 3D environment for virtual training, which may guide the patients to take the training actively.
3.Active control of the trajectory of the center of gravity in balance training
Renling ZOU ; Xiufang HU ; Xiulin XU ; Fang LI ; Yi WU
Chinese Journal of Physical Medicine and Rehabilitation 2011;33(2):137-140
Objective To study the impact of active control of the trajectory of the center of gravity on the effectiveness of balance training and balance assessment. Methods Two groups of subjects ( group 1 30-45 years old, group 2 45-60 years old ) were evaluated and trained using both active center of gravity trajectory control and static balance methods. Results The percentages of success in controlling the center of gravity were the same when both groups were trained using static balance. Group 1's success percentage was higher than that of group 2 after active center of gravity trajectory training. Their affected lower limbs performed better in wave trace training than after static balance training, and performance improved with increased wave trace amplitude. Conclusions Wave tracing can stimulate the lower limbs of patients with active control force and improve their balance. The wave assessment is superior to static assessment, as it can objectively reflect ability in active center of gravity control and adjust the lower limbs of subjects whose static balance ability is at the same level.
4.Design of balloon dilatation device for achalasia of cricopharyngeal muscle
Renling ZOU ; Xiufang HU ; Xiulin XU ; Yi WU
Chinese Journal of Tissue Engineering Research 2009;13(52):10309-10312
Obstacles in pharyngoesophageal function are characterized clinically by dysphagia.At present,the treatment for dysphagia is broadly divided into two ways:balloon expansion therapy and electrical stimulation therapy.Balloon dilatation device for achalasia of cricopharyngeal muscle is design based on the principle of expansion treatment to stimulate cricopharyngeal muscle contraction and dilatation through the pressure of balloon dilation.At work,the water was filled in balloon catheter through the electronic charge pump to pressurize to reach a certain pressure of the balloon dilatation,and the drain valve drained water at prescriptive speed until it reaches a certain contraction of the balloon pressure,followed by water filling in the balloon catheter.This operation was repeated operation,resulting in a compression cycle to cricopharyngeal muscle,promote its contraction and dilatation.Patients can gradually restore autonomy of swallowing.The device is easy to operate,safe and reliable.The doctor can fill water in the balloon catheter at certain time and quantity to achieve the treatment of achalasia of cricopharyngeal muscle.
5.Current research of L-amino acid transporter 1 in tumor diagnosis and treatment
Yan DONG ; Weidang WU ; Xiaoyan CI ; Jing GAO ; Yong ZENG ; Xiulin YI
Tianjin Medical Journal 2015;(12):1456-1459
L-amino acid transporter 1 ( LAT1) is a member of L-amino transporter family and an important heterodi?meric amino acid transporter that belongs to subfamily of SLC7. LAT1 mainly mediates trans-membrane transportation of those neutral amino acids that had cyclobenzene or long side chains with high molecular mass such as L-Leu, L-Met and L-Phe as well as some amino acid analogues such as melphalan, L-DOPA and thyroxine in a Na+and ATP-independent diffu?sion. As LAT1 was abnormally overexpressed in various transformed cell lines, it might be related with tumor stage and prog?nosis. It is not only a biomarker that specifically expressed in some tumor cells but also plays an important role in tumor diag?nosis and therapy. Here we demonstrate the structure of LAT1 and its mechanism in transport peculiarity. We also reviewed the development of LAT1 in tumor diagnosis and treatment.
6.Inhibition of berberine on organ anion transporters and its bidirectional trans-membrane transport
Weidang WU ; Xingyan ZHANG ; Zihong WEI ; Xiaoyan CI ; Lixin JIANG ; Jiangjie LU ; Changxiao LIU ; Xiulin YI
Drug Evaluation Research 2017;40(6):778-782
Objective To study the inhibition of berberine on organ anion transporters (OATs) and its bidirectional trans-membrane transport.Method The transgene cell lines of the organ anion transporters including OAT1,OAT2,OAT3,OAT4,OAT7,and URAT1 were constructed and selected by animal cell transgenic method mediated by transporter Lipo 3000.Wild type (WT) cells were used as control group,and activity of OATs was verified by adding their radiolabeled substrates and inhibitors.The inhibition of 100 μmol/L berberine on the transporters was investigated in vitro.The IC50 of berberine on URAT1 was also determined.The bidirectional transport of berberine was studied through the Caco-2 model.Result The results showed that 100 μmol/L berberine inhibited the activity of OAT1,OAT2,OAT3,OAT4,OAT7 and URAT1 to (70.48±4.23)%,(69.13±1.28)%,(72.12±3.28)%,(79.77±6.49)%,(69.51 ±5.99)% and (38.4 ± 2.67)% respectively,the IC50 of berberine to URAT 1 was 13.19 μmol/L,the Papp (A-B) of 50 μmol/L and 100 μmol/L berberine were separately 0.28 × 10-6 and 0.40 × 10-6 cm/s,and the effiux rates were separately 3.18 and 3.15.Conclusion Berberine shows a stronger inhibition to URAT1 compared to OAT1,OAT2,OAT3,OAT4 and OAT7.Berberine may be the substrate of some effiux transporters.This study provides theoretical basis for explaining the low bioavailability ofberberine and forecasting the possible drug-drug interaction.
7.Potential synergic mechanism of Wutou-Gancao herb-pair by inhibiting efflux transporter P-glycoprotein
Yufei HE ; Zihong WEI ; Ying XIE ; Xiulin YI ; Yong ZENG ; Yazhuo LI ; Changxiao LIU
Journal of Pharmaceutical Analysis 2020;10(2):178-186
Wutou-Gancao herb-pair is extensively used to attenuate the toxicity and enhance the efficacy of aconite. In this study, potential synergic mechanism of the herb pair was investigated by utilizing multiple ap-proaches. In silico and in vitro Caco-2 cell models were applied to study the potential binding mode of bioactive ingredients existing in liquorice with P-glycoprotein (P-gp), as well as the inhibition effects on P-gp. Additionally, anti-inflammatory activity of aconitine (AC) combined with active ingredients of liquorice, as well as pharmacokinetic patterns of AC after co-administration was investigated. Anti-inflammatory effect of AC (1 mg/kg) in rats was enhanced in combination with bioactive ingredients of liquorice (10 mg/kg). In the meanwhile, the exposure of AC in vivo was altered, in terms of Cmax and AUC. For instance, the Cmax and AUC were increased to 1.9 and 1.3 folds, respectively, when used in combination with liquiritigenin. The in silico study revealed the potential binding mode with outward facing conformation of P-gp. The resulting data obtained from transport of rhodamine-123 (Rh-123) across Caco-2 cell monolayer further indicated that the function of P-gp was inhibited by chemicals in liquorice. The synergic effect was therefore proposed to be attributed to inhibition of P-gp by liquorice since AC has been demonstrated to be the substrate of P-gp. The resuls revealed that potential synergic mechanism of Wutou-Gancao herb-pair by inhibiting function of key efflux transporter P-gp to enhance the exposure of AC in systematic circulation, and further the anti-inflammatory effect, which helps clarify the compatibility rationale of these two herbs.
8.Inhibition of berberine on organ cation transporters
Weidang WU ; Tao CUI ; Xingyan ZHANG ; Zihong WEI ; Xiaoyan CI ; Jiangjie LU ; Lixin JIANG ; Changxiao LIU ; Xiulin YI
Drug Evaluation Research 2017;40(5):633-637
Objective To study the inhibitory effects ofberberine on human organic cation transporter (OCTs) including OCT1,OCT2,OCT3,OCTN1 and OCTN2.Methods Using animal cell transgenic method mediated by transporter Lipo 3000,the drug transporters over expression cell lines S2-OCT1,S2-OCT2,S2-OCT3,S2-OCTN1 and S2-OCTN2 were obtained by selective medium culture.The OCTs evaluation model was established by detecting the trans-membrane transport of radioactive substrate in vitro.Wild type (WT) cells were used as control group,activity of OCTs was verified by adding its inhibitor.The inhibition of berberine on the transporters was investigated in vitro.The IC50 of inhibitory effect of berberine on various drug transporters was also calculated.Result The transport activity of transporter cell lines was increased by more than 5 times compared to the WT cell line respectively,what's more,their transport activity decreased significantly by their corresponding inhibitor.The ICs0 of berberine to OCT1,OCT2,OCT3,OCTN1 and OCTN2 were respectively 7.63,6.80,2.25,4.66 and 210.34 μmol/L.Conclusion Berberine significant inhibition to OCT1,OCT2,OCT3,OCTN1 and OCTN2.The inhibition on OCT1,OCT2,OCT3,OCTN1 is stronger compared to OCTN2.
9.Evaluation of tolerance and pharmacodynamics of nano-micelle irinotecan formulation
Tao CUI ; Weidang WU ; Xiaoyan CI ; Wei LI ; Chuanmin GUO ; Jing XU ; Xiulin YI ; Changxiao LIU
Journal of China Pharmaceutical University 2019;50(2):175-179
This study aimed to investigate the improvement of tolance and pharmacodynamics of nano-micelle irinotecan formulation compared with irinotecan hydrochloride injection(Campto). The toxic effects of the two formulations on colorectal cancer cells COLO205, HT-29, HCT-8 and SW480 were tested in vitro. COLO205 tumor-bearing mouse model was constructed. The two preparations were given via tail vein injection to investigate the maximum tolerance dose(MTD)of tumor-bearing mice to the two preparations, and then to explore the improvement of anti-tumor efficacy of nano-micelle irinotecan formulation near the MTD. The results showed that there was no significant difference in the inhibitory effect of the two formulations on the four colorectal cancer cells in vitro. The MTD of nano-micelle irinotecan formulation and Campto was 432. 0 and 276. 5 mg/m2 respectively. Both of the two formulations showed significant anti-tumor effect in vivo, and the relative tumor proliferation rate and tumor wet weight inhibition rate of nano-micelle irinotecan formulation at high dose(345. 6 mg/m2)were significantly better than those of Campto at two doses(177. 0 and 221. 2 mg/m2)(P< 0. 05).
10.Establishment of the patient derived liver cancer xenograft model
Pinsheng HAN ; Long YANG ; Tao CUI ; Wen TONG ; Yu MIAO ; Ce XU ; Xiulin YI ; Yamin ZHANG
Chinese Journal of Hepatobiliary Surgery 2022;28(4):295-298
Objective:To establish the patient derived xenograft (PDX) model of liver malignant tumor, analyze the related factors affecting the carcinogenesis of PDX model, and analyze the differences of biological characteristics between the primary tumor and PDX model.Methods:Fresh liver malignant tumor tissue samples were collected from the patients who received the surgery from the Tianjin First Central Hospital and the samples were inoculated subcutaneously into BALB/c-nu mice. The correlations between clinicopathological information and tumor formation rate were analyzed, and the pathological morphology and specific protein expression of PDX model and primary tumor were compared.Results:Thirty-three PDX models were successfully established from 63 cases of liver malignant tumors. The overall tumor formation rate was 52.4% (33/63), including 46.3% (25/54) of primary liver cancer and 88.9% (8/9) of liver metastasis. The main factors affecting the tumor formation rate were tumor pathological type, distant metastasis and TNM stage (all P<0.05). The pathological morphology and specific protein expression of PDX model and primary tumor were similar. Conclusion:The PDX model of liver malignant tumor was successfully constructed, and the tumor formation rate was high, and can maintain the biological characteristics of the primary tumor.